ArticleBMC pulmonary medicine2026
Identification of risk factors and development of a predictive model for early renal impairment in patients with obstructive sleep apnea-hypopnea syndrome.
Article in BMC pulmonary medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
objectiveThis study aims to identify independent risk factors associated with early renal impairment in patients with obstructive sleep apnea-hypopnea syndrome (OSAHS) and to develop a predictive model for individualized risk stratification.
methodsThis retrospective cross-sectional study included 259 patients with a confirmed diagnosis of OSAHS based on overnight polysomnography (PSG). Participants were classified into two groups based on urine albumin-to-creatinine ratio (UACR) and estimated glomerular filtration rate (eGFR): a normal renal function group (n = 173) and an early renal impairment group (n = 86). Data on demographic variables, clinical comorbidities, PSG-derived indices, and laboratory parameters were collected. Univariate and multivariate logistic regression analyses were performed to identify independent predictors of early renal impairment. A nomogram was subsequently developed, with its performance assessed using receiver operating characteristic (ROC) curve analysis, the Hosmer-Lemeshow goodness-of-fit test, decision curve analysis (DCA), and bootstrap internal validation.
resultsMultivariate analysis identified elevated body mass index, presence of hypertension and diabetes mellitus, increased cumulative time with oxygen saturation below 90%, higher levels of high-sensitivity C-reactive protein, and elevated serum cystatin C as independent risk factors for early renal impairment. Conversely, higher minimum nocturnal oxygen saturation was identified as a protective factor. The constructed nomogram demonstrated good discriminatory capacity (area under the ROC curve = 0.796) and calibration (Hosmer-Lemeshow test, p = 0.231). DCA supported its clinical utility within a predicted probability range of 0.2-0.8.
conclusionEarly renal impairment in patients with OSAHS is significantly associated with obesity, cardiometabolic comorbidities, hypoxemia-related burden, and systemic inflammation. The developed nomogram showed acceptable discrimination and calibration and may serve as a preliminary tool for individualized risk stratification in patients with OSAHS.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.